Epigenetic factors in atherogenesis: MicroRNA


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

MicroRNAs (miRNAs) are small (~22 nucleotides in length) noncoding RNA sequences regulating gene expression at the posttranscriptional level. MicroRNAs bind complementarily to certain mRNA and cause gene silencing. miRNAs are involved in plaque formation and rapture, regulation of cholesterol metabolism, inflammatory response, cell cycle progression and proliferation, platelet activation; they also influence functions of endothelial and vascular smooth muscle cells (VSMC). This suggests their important roles in initiation and progression of atherosclerosis. MicroRNAs play a key role in the development of cardiovascular diseases (CVDs), including atherosclerosis. The use of antisense oligonucleotides is considered as promising technique for targeted changes in gene expression both in vitro and in vivo. In this review, we consider the role of miRNAs in progression of atherosclerosis, their use as potential biomarkers and targets in the treatment of CVDs, as well as possible application of antisense oligonucleotides.

Sobre autores

A. Smirnova

Institute for Atherosclerosis Research

Autor responsável pela correspondência
Email: annatrubinova@gmail.com
Rússia, Moscow, 121609

V. Sukhorukov

Laboratory of Angiopathology

Email: annatrubinova@gmail.com
Rússia, ul. Baltiyskaya 8, Moscow, 125315

V. Karagodin

Plekhanov Russian University of Economics

Email: annatrubinova@gmail.com
Rússia, Stremyanny per. 36, Moscow, 117997

A. Orekhov

Institute for Atherosclerosis Research; Laboratory of Angiopathology

Email: annatrubinova@gmail.com
Rússia, Moscow, 121609; ul. Baltiyskaya 8, Moscow, 125315

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2016